|
|
Volumn 324, Issue 7345, 2002, Pages 1053-
|
|
FDA advisory panels recommend Lotronex be put back on market.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOSETRON;
CARBOLINE DERIVATIVE;
GASTROINTESTINAL AGENT;
ADVISORY COMMITTEE;
ARTICLE;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
IRRITABLE COLON;
POSTMARKETING SURVEILLANCE;
UNITED STATES;
ADVISORY COMMITTEES;
CARBOLINES;
COLONIC DISEASES, FUNCTIONAL;
DRUG APPROVAL;
GASTROINTESTINAL AGENTS;
HUMANS;
PRODUCT SURVEILLANCE, POSTMARKETING;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 19044368382
PISSN: None
EISSN: 14685833
Source Type: Journal
DOI: 10.1136/bmj.324.7345.1053/a Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|
